Janux Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Janux Therapeutics Operating Expenses Growth & History (JANX)
Janux Therapeutics's operating expenses was $167.7M for fiscal 2025.
View full Janux Therapeutics company overviewJanux Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $167.7M | $58.2M | +53.21% |
| 2024 | 2024-12-31 | $109.4M | $28.4M | +35.00% |
| 2023 | 2023-12-31 | $81.1M | $5.4M | +7.08% |
| 2022 | 2022-12-31 | $75.7M | $39.1M | +107.03% |
| 2021 | 2021-12-31 | $36.6M | $31.7M | +655.03% |
| 2020 | 2020-12-31 | $4.8M | — | — |
Janux Therapeutics quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $42.0M | −$3.2M | −7.01% |
| Q1 2026 | 2026-03-31 | $37.9M | $3.0M | +8.74% |
| Q4 2025 | 2025-12-31 | $42.4M | $13.4M | +46.10% |
| Q3 2025 | 2025-09-30 | $45.3M | $9.0M | +24.72% |
| Q2 2025 | 2025-06-30 | $45.1M | $22.4M | +98.59% |
| Q1 2025 | 2025-03-31 | $34.9M | $13.5M | +62.97% |
| Q4 2024 | 2024-12-31 | $29.0M | $10.4M | +56.05% |
| Q3 2024 | 2024-09-30 | $36.3M | $18.0M | +97.93% |
| Q2 2024 | 2024-06-30 | $22.7M | $914,000 | +4.19% |
| Q1 2024 | 2024-03-31 | $21.4M | −$916,000 | −4.10% |
| Q4 2023 | 2023-12-31 | $18.6M | −$2.5M | −11.90% |
| Q3 2023 | 2023-09-30 | $18.3M | −$1.5M | −7.59% |
| Q2 2023 | 2023-06-30 | $21.8M | $2.2M | +11.10% |
| Q1 2023 | 2023-03-31 | $22.3M | $7.2M | +47.57% |
| Q4 2022 | 2022-12-31 | $21.1M | $6.0M | +39.75% |
| Q3 2022 | 2022-09-30 | $19.8M | $7.8M | +64.44% |
| Q2 2022 | 2022-06-30 | $19.6M | $12.9M | +191.45% |
| Q1 2022 | 2022-03-31 | $15.1M | $12.5M | +467.98% |
| Q4 2021 | 2021-12-31 | $15.1M | — | — |
| Q3 2021 | 2021-09-30 | $12.1M | $10.8M | +860.35% |
| Q2 2021 | 2021-06-30 | $6.7M | $5.6M | +508.86% |
| Q1 2021 | 2021-03-31 | $2.7M | — | — |
| Q3 2020 | 2020-09-30 | $1.3M | — | — |
| Q2 2020 | 2020-06-30 | $1.1M | — | — |
Janux Therapeutics operating expenses trends
Over the last five fiscal years, Janux Therapeutics's operating expenses increased from $4.8M to $167.7M, a change of $162.8M. The latest reported quarter, Q2 2026, shows $42.0M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Janux Therapeutics source filings ↗